Tandem Diabetes Care | الدين





الدين تغيير تاريخ
Abbott USD 12.94B 496M 2025-09
Accuray USD 170.24M 4.52M 2024-09
Align Technology USD 121.27M 1.75M 2025-09
AtriCure USD 76.73M 521K 2025-09
Baxter International USD 9.71B 13M 2025-09
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 12.05B 19M 2025-09
Cooper Companies USD 2.48B 285.1M 2025-06
Dexcom USD 1.24B 1.21B 2025-12
Edwards Lifesciences USD 700.3M 2.3M 2025-09
Eli Lilly USD 42.51B 2.6B 2025-09
Globus Medical USD 119.34M 1.76M 2025-09
ICU Medical USD 1.28B 79.88M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 1.01B 384.9M 2025-09
Integra LifeSciences USD 2.01B 7.91M 2025-09
Intuitive Surgical USD 0 0 2025-03
J&J USD 45.8B 4.97B 2025-09
Masimo USD 586.2M 56M 2025-09
Medtronic USD 29.1B 491M 2025-09
Merit Medical Systems USD 821.15M 599K 2025-09
Orthofix International USD 137.23M 338K 2024-09
Roche Holding CHF 33.03B 1.41B 2025-06
Stryker USD 14.86B 1.74B 2025-12
Tandem Diabetes Care USD 449.28M 276K 2025-09
Teleflex USD 2.77B 774M 2025-09
Zimmer Biomet Holdings USD 7.52B 593.5M 2025-12


Tandem Diabetes Care الدين - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Feb 2026.